Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
Line 68: | Line 68: | ||
| SPECT Ioflupane in Neurodegenerative Disease v1.1 | | SPECT Ioflupane in Neurodegenerative Disease v1.1 | ||
| Public Comment | | Public Comment | ||
− | | 12.31 | + | | 2016.12.31 |
| [[Media: SPECT Profile Response to Public Comments.v2017 06 06.xlsx | Public Comment Resolutions 2017-06-06]] | | [[Media: SPECT Profile Response to Public Comments.v2017 06 06.xlsx | Public Comment Resolutions 2017-06-06]] | ||
|- | |- |
Revision as of 23:47, 16 June 2020
Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.